GLOW is typically 70 mg total: 10 mg BPC-157, 10 mg TB-4, 50 mg GHK-Cu
Getting a personalized compounded GLP-1 still requires a prescription
A substudy of this phase 1b trial showed also that retatrutide delays gastric emptying in humans, as measured by the acetaminophen test, though this effect lessens over time due to tachyphylaxis [44]
And in 2021, the FDA approved a more potent dose of injectable semaglutide, this time under the brand name Wegovy
While not specifically approved for weight loss, many clients experience weight reduction as a secondary benefit
Experimentally it has been demonstrated to accelerate the healing of many different wounds, including tendons, muscles, nervous system and superior healing of damaged ligaments